News

Mitochondrial DNA Damage Linked to Vascular Alterations in Diabetics

Increased mitochondrial DNA damage in peripheral blood mononuclear cells of patients with diabetes mellitus and clinical atherosclerotic cardiovascular disease is associated with microvascular alterations, specifically, microvascular pulsability. The study, “Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease,” was published in the journal Cardiovascular Diabetology.

Drug to Treat Mitochondrial-related Heart Failure Shows Promise in Clinical Trial, Company Reports

Stealth BioTherapeutics presented new clinical trial data during the recent American College of Cardiology’s 65th Annual Scientific Session in Chicago, showing that its lead candidate elamipretide is both safe and well-tolerated in patients with heart failure. At the April 2–4 meeting, the company also reported demonstrated improvements in major secondary efficacy study measures, and that future…

Mitochondria Dysfunction Seen to Affect Interneuron Development in Brains of Mice, Possibly Leading to Neurological Disorders

Mitochondria dysfunction disrupts normal development of interneurons, which may underlie the neurological symptoms of autism spectrum disorder, according to the results of a recent study, “Differential Mitochondrial Requirements for Radially and Non-radially Migrating Cortical Neurons: Implications for Mitochondrial Disorders,” published in the journal Cell Reports. Mitochondria are key organelles…

Gene Therapy May Rescue Visual Acuity in People with LHON Disease

In a study in the journal Scientific Reports, researchers propose that gene therapy may be a safe and efficient strategy to treat Leber’s hereditary optic neuropathy disease (LHON). The study is titled “Efficacy and Safety of rAAV2-ND4 Treatment for Leber’s Hereditary Optic Neuropathy.” LHON is a neurodegenerative mitochondria disease that leads to blindness.